Advertisement

Index by author

November 01, 1999; Volume 291,Issue 2

  1. Brimecombe, Jessica C.

    1. A Critical Role of theN-Methyl-d-aspartate (NMDA) Receptor Subunit (NR) 2A in the Expression of Redox Sensitivity of NR1/NR2A Recombinant NMDA Receptors
      Jessica C. Brimecombe, William K. Potthoff and Elias Aizenman
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 785-792;

  2. Brown, R. Dale

    1. α-Adrenoceptors in Canine Mesenteric Artery Are Predominantly 1A Subtype: Pharmacological and Immunochemical Evidence
      E. E. Daniel, R. Dale Brown, Y. F. Wang, A. M. Low, H. Lu-Chao and C.-Y. Kwan
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 671-679;

  3. Burritt, Andrew

    1. High-Affinity Interaction of (des-Tyrosyl)Dynorphin A(2-17) with NMDA Receptors
      Qingbo Tang, Ronnie Gandhoke, Andrew Burritt, Victor J. Hruby, Frank Porreca and Josephine Lai
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 760-765;

  4. Busch, Andreas E.

    1. ATP-Sensitive Potassium Channel Blocker HMR 1883 Reduces Mortality and Ischemia-Associated Electrocardiographic Changes in Pigs with Coronary Occlusion
      Klaus J. Wirth, Björn Rosenstein, Jörg Uhde, Heinrich C. Englert, Andreas E. Busch and Bernward A. Schölkens
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 474-481;

  5. Buscher, Rainer

    1. Variability in Phenylephrine Response and Essential Hypertension: A Search for Human α1B-Adrenergic Receptor Polymorphisms
      Rainer Büscher, Volker Herrmann, Kevin M. Ring, Mala T. Kailasam, Daniel T. O’Connor, Robert J. Parmer and Paul A. Insel
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 793-798;

  6. Caffrey, James L.

    1. Canine Cardiac Muscarinic Receptors, G Proteins, and Adenylate Cyclase after Long-Term Morphine
      Leslie D. Napier, Sandra C. Roerig, Darice A. Yoshishige, Barbara A. Barron and James L. Caffrey
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 725-732;

  7. Callahan, Michael J.

    1. Milameline (CI-979/RU35926): A Muscarinic Receptor Agonist with Cognition-Activating Properties: Biochemical and In Vivo Characterization
      Roy D. Schwarz, Michael J. Callahan, Linda L. Coughenour, Melvin R. Dickerson, Jack J. Kinsora, William J. Lipinski, Charlotte A. Raby, Carolyn J. Spencer and Haile Tecle
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 812-822;

  8. Carlson, Edward C.

    1. A Transgenic Model of Acetaldehyde Overproduction Accelerates Alcohol Cardiomyopathy
      Qiangrong Liang, Edward C. Carlson, Anthony J. Borgerding and Paul N. Epstein
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 766-772;

  9. Case, Jennifer

    1. Estrogen Alters Relative Contributions of Nitric Oxide and Cyclooxygenase Products to Endothelium-Dependent Vasodilation
      Jennifer Case and Cathy A. Davison
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 524-530;

  10. Castagnoli, Kay

    1. Species-Dependent Differences in Monoamine Oxidase A and B-Catalyzed Oxidation of Various C4 Substituted 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridinyl Derivatives
      Hiroyuki Inoue, Kay Castagnoli, Cornelis Van der Schyf, Stéphane Mabic, Kazuo Igarashi and Neal Castagnoli
      Journal of Pharmacology and Experimental Therapeutics November 1999, 291 (2) 856-864;
« Previous (Pages : 1 2 3 4 5 6 7 8 9 ... 35) Next »
Back to top

In this issue

Advertisement